Soluble endoglin in urine as an early-pregnancy preeclampsia marker: antenatal longitudinal feasibility study

References

• 2018. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstetrics and Gynecology 132:e44–e52.
   Google Scholar
• 2019. ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstetrics and Gynecology 133:e1–e25.
   PubMed Web of Science ®Google Scholar
• Allen R, Aquilina J. 2018. Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes. Journal of Maternal-Fetal & Neonatal Medicine 31:2789–2806.
   PubMed Web of Science ®Google Scholar
• Alper AB, Yi Y, Rahman M, Webber LS, Magee L, Von Dadelszen P, et al. 2011. Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. American Journal of Perinatology 28:425–430.
   PubMed Web of Science ®Google Scholar
• Baweja S, Kent A, Masterson R, Roberts S, McMahon LP. 2011. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography. BJOG 118:1126–1132.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, US Preventive Services Task Force, et al. 2017. Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement. JAMA 317:1661–1667.
   PubMed Web of Science ®Google Scholar
• Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodríguez JI, Sánchez-Rodríguez A, López-Novoa JM, Martínez-Salgado C. 2010. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients. BMC Medicine 8:86.
   PubMed Web of Science ®Google Scholar
• Brown CM, Garovic VD. 2011. Mechanisms and management of hypertension in pregnant women. Current Hypertension Reports 13:338–346.
   PubMed Web of Science ®Google Scholar
• Brownfoot F, Kaitu'u-Lino T, Beard S, Tong S, Hannan N. 2017. sFlt-1 and soluble endoglin concentrations in serum vs plasma in preterm preeclampsia: are they interchangeable for biomarker studies. ? Pregnancy Hypertension 10:18–21.
   PubMed Web of Science ®Google Scholar
• Buhimschi C, Baumbusch M, Dulay AT, Lee S, Wehrum M, Zhao G, et al. 2010. The role of urinary soluble endoglin in the diagnosis of pre‐eclampsia: comparison with soluble fms‐like tyrosine kinase 1 to placental growth factor ratio. BJOG 117:321–330.
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Nayeri UA, Zhao G, Shook LL, Pensalfini A, Funai EF, et al. 2014. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Science Translational Medicine. 6:245ra92.
   PubMed Web of Science ®Google Scholar
• Caillon H, Tardif C, Dumontet E, Winer N, Masson D. 2018. Evaluation of sFlt-1/PlGF ratio for predicting and improving clinical management of pre-eclampsia: experience in a specialized perinatal care center. Annals of Laboratory Medicine 38:95–101.
   PubMed Web of Science ®Google Scholar
• Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, et al. 2011. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 32 Suppl:S4–S16.
   PubMed Web of Science ®Google Scholar
• Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G, Yildizhan R. 2017. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia. Journal of Maternal–Fetal & Neonatal Medicine 30:1602–1607.
   PubMed Web of Science ®Google Scholar
• David A, Padmaja P. 2016. Calcium-to-creatinine ratio in a spot sample of urine, for early prediction of hypertensive disorders of pregnancy: a prospective study. Journal of Obstetrics and Gynecology of India 66:94–97.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. 2013. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstetrics and Gynecology 122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Ueda Y, Hoshimoto K, Ota Y, Fukasawa I, Sumori K, et al. 2002. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. American Journal of Kidney Diseases 39:392–400.
   PubMed Web of Science ®Google Scholar
• Kang JH, Song H, Yoon JA, Park DY, Kim SH, Lee KJ, et al. 2011. Preeclampsia leads to dysregulation of various signaling pathways in placenta. Journal of Hypertension 29:928–936.
   PubMed Web of Science ®Google Scholar
• Kao CK, Morton JS, Quon AL, Reyes LM, Lopez-jaramillo P, Davidge ST. 2016. Mechanism of vascular dysfunction due to circulating factors in women with preeclampsia. Clinical Science 130:539–549.
   PubMed Web of Science ®Google Scholar
• Kar M. 2014. Role of biomarkers in early detection of preeclampsia. Journal of Clinical and Diagnostic Research 8:BE01–4.
   PubMedGoogle Scholar
• Kuromoto K, Watanabe M, Adachi K, Ohashi K, Iwatani Y. 2010. Increases in urinary creatinine and blood pressure during early pregnancy in pre-eclampsia. Annals of Clinical Biochemistry 47:336–342.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. 2006. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England Journal of Medicine 355:992–1005.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Karumanchi SA. 2011. Angiogenic factors and preeclampsia. Seminars in Nephrology 31:33–46.
   PubMed Web of Science ®Google Scholar
• Park JH, Chung D, Cho HY, Kim YH, Son GH, Park YW, Kwon JY. 2013. Random urine protein/creatinine ratio readily predicts proteinuria in preeclampsia. Obstetrics & Gynecology Science 56:8–14.
   PubMedGoogle Scholar
• Polsani S, Phipps E, Jim B. 2013. Emerging new biomarkers of preeclampsia. Advances in Chronic Kidney Disease 20:271–279.
   PubMed Web of Science ®Google Scholar
• Teixeira PG, Reis ZSN, Andrade SP, Rezende CA, Lage EM, Velloso EP, et al. 2013. Presymptomatic prediction of preeclampsia with angiogenic factors, in high risk pregnant women. Hypertension in Pregnancy 32:312–320.
   PubMed Web of Science ®Google Scholar
• Vittinghoff E, McCulloch CE. 2007. Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology 165:710–718.
   PubMed Web of Science ®Google Scholar
• Waikar SS, Sabbisetti VS, Bonventre JV. 2010. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney International 78:486–494.
   PubMed Web of Science ®Google Scholar
• Wiles K, Bramham K, Seed PT, Nelson-Piercy C, Lightstone L, Chappell LC. 2019. Serum creatinine in pregnancy: a systematic review. Kidney International Reports 4:408–419.
   PubMed Web of Science ®Google Scholar
• Yusuf AM, Kahane A, Ray JG. 2018. First and second trimester serum sFlt-1/PlGF ratio and subsequent preeclampsia: a systematic review. Journal of Obstetrics and Gynaecology Canada 40:618–626.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. 2016. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. New England Journal of Medicine 374:13–22.
   PubMed Web of Science ®Google Scholar